NexImmune, Inc.  announced the formation of its Autoimmune and Infectious Disease Scientific Advisory Board (AI & ID SAB). NexImmune's AI and ID SAB members include: Gerald (Jerry) Nepom, MD, PhD (Chair), Director, Immune Tolerance Network; Member Benaroya Research Institute at Virginia Mason (Seattle); Professor (Affil) Department of Immunology, University of Washington School of Medicine. David Hafler, MD, William S. and Lois Stiles Edgerly Professor of Neurology; Professor of Immunology and Chairman, Department of Neurology, Yale University School of Medicine; Neurologist-in-Chief, Yale New Haven Hospital; Visiting Scientist, Broad Institute of MIT and Harvard.

Kevan Herold, MD, C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology), Yale University; Deputy Director, Yale Center for Clinical Investigation; Co-Director, Yale Diabetes Center. James Krueger, MD, PhD, Chief Executive Officer, Co-director for the Center for Clinical and Translational Science, Senior Attending Physician, D. Martin Carter Professor in Clinical Investigation and Laboratory Head of Investigative Dermatology, The Rockefeller University Hospital. Robin Robinson, PhD, Chief Scientific Officer, RenovaCare, Inc.; former Director, Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Dept.

of Health and Human Services. Robert Siliciano, MD, PhD, Professor of Infectious Diseases, Johns Hopkins Medical Institute; Investigator, Howard Hughes Medical Institute. Jeffrey (Jeff) S. Weber, MD, PhD, Deputy Director and Head, Experimental Therapeutics, Co-Director of the Melanoma Research Program, Laura and Isaac Comprehensive Perlmutter Cancer Center at NYU Langone Health; Professor of Medicine, NYU Grossman School of Medicine.